Qiming U.S. Healthcare Fund II, L.P.

Insider Reports History

Entity
Company
Location
350 106 Th Avenue Ne, 1 St Floor, Bellevue, WA
Signature
Qiming U.S. Healthcare Fund II, L.P., By: Qiming U.S. Healthcare GP II, LLC, its general partner, By /s/ Mark McDade, Managing Partner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Qiming U.S. Healthcare Fund II, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Icosavax, Inc. Former 10% Owner Common Stock 3.52M $55.2M $15.67 Aug 2, 2021 Direct
Jasper Therapeutics, Inc. 10%+ Owner Voting Common Stock 8.52M $5.53M $0.65 Jan 27, 2023 Direct
Elevation Oncology, Inc. 10%+ Owner Common Stock 2.37M $1.21M $0.51 Jun 29, 2021 Direct
Elevation Oncology, Inc. 10%+ Owner Series A Preferred Stock 0 Jun 29, 2021 Direct
Elevation Oncology, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 29, 2021 Direct
Icosavax, Inc. Former 10% Owner Series A-1 Preferred Stock 0 Aug 2, 2021 Direct
Icosavax, Inc. Former 10% Owner Series B-1 Preferred Stock 0 Aug 2, 2021 Direct

Insider Reports Filed by Qiming U.S. Healthcare Fund II, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JSPR Jasper Therapeutics, Inc. Jan 27, 2023 1 $4M 4 Apr 11, 2023 10%+ Owner
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 1, 2021 10%+ Owner
ICVX Icosavax, Inc. Aug 2, 2021 6 $3.32M 4 Aug 2, 2021 Former 10% Owner
ICVX Icosavax, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 Director, 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 29, 2021 5 $5M 4 Jul 1, 2021 10%+ Owner
ELEV Elevation Oncology, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner